Home › Pagkabigo ng Puso › Florida › Orlando
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Orlando, FL
16 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orlando (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Nagre-recruitPhase 2
- AdventHealth Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi ang layo
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Nagre-recruitPhase 3
- AdventHealth, Orlando
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Nagre-recruitPhase 3
- Clinical Site Partners, LLC, Winter Park · 5 mi ang layo
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Nagre-recruitPhase 3
- Clinical Site Partners, LLC, Winter Park · 5 mi ang layo
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · 5 mi ang layo
- at 1 pa
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Orlando
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Nagre-recruitPhase 1
- Flourish Research, Winter Park · 5 mi ang layo
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Nagre-recruit
- Advent Health, Orlando
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Nagre-recruit
- Orlando Health, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi ang layo
- K2 Medical Research, Maitland · 6 mi ang layo
Alleviant ALLAY-HF Study
Nagre-recruit
- Advent Health Orlando, Orlando
Assessment of CCM in HF With Higher Ejection Fraction
Nagre-recruit
- AdventHealth Orlando, Orlando
- Revival Clinical Research, Orlando
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Nagre-recruitPhase 2
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi ang layo
CCM OPEN HF Registry
Nagre-recruitObservasyonal na pag-aaral
- AdventHealth Orlando, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Nagre-recruitPhase 3
- AdventHealth, Orlando
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY50 pag-aaral
- Boston, MA43 pag-aaral
- Dallas, TX42 pag-aaral
- Houston, TX36 pag-aaral
- Cleveland, OH33 pag-aaral
- Chicago, IL32 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- St. Louis, MO26 pag-aaral
- Durham, NC26 pag-aaral
- Kansas City, MO25 pag-aaral
- Atlanta, GA25 pag-aaral
Iba pang pag-aaral sa Orlando
- Non-Small Cell Lung Cancer44 pag-aaral
- Metastatic Cancer29 pag-aaral
- Obesity29 pag-aaral
- Kanser (lahat ng uri)25 pag-aaral
- Sakit ni Alzheimer25 pag-aaral
- Overweight25 pag-aaral
- Type 2 Diabetes24 pag-aaral
- Kanser sa Suso23 pag-aaral
- Ulcerative Colitis23 pag-aaral
- Kanser sa Ovary22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Colorectal Cancer19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.